Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

Basilar Migraine Clinical Trial

Official title: A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

Status Completed

Clinical Trial Summary

The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.

Clinical Trial Description

The objective of this study is to assess the efficacy and safety of topiramate in the prophylaxis of basilar migraine and hemiplegic migraine in children and adolescents, by comparing two doses, 25 and 100 mg/day. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

• Basilar Migraine
• Migraine Disorders

• NCT number: NCT00131443
• Study type: Interventional
• Source: Monarch Medical Research
• Status: Completed
• Phase: Phase 2/Phase 3
• Start date: February 2004
• Completion date: August 2006